November 29, 2019

Press release

Interim Report Third Quarter 2019

FluoGuide A/S (“FluoGuide”) today announces its results for the period 01/July/2019 – 30/Sep/2019. The full report is available on the company’s... [Read more]

November 25, 2019

News

FluoGuide presentation at Sedermeradagen in Stockholm and Investordagen in Aalborg

FluoGuide A/S’s (“FluoGuide”) presented the company and its preparation of FG001 for the proof-of-concept study progresses accordingly to plan. At Sedermeradagen... [Read more]

November 25, 2019

Press release

FluoGuide A/S: Change of report date

FluoGuide A/S will publish its interim report for third quarter 2019 on 29 November 2019. Previously communicated date was 30 November... [Read more]

September 20, 2019

News

Presentation of FluoGuide at Life Science Investorkonference Q3 2019

Presentation from FluoGuide at Life Science Investorkonference FluoGuide A/S (“FluoGuide”, ticker FLUO) was presented at the 18 September at the Life... [Read more]

September 7, 2019

Press release

Presentation of data where FG001 demonstrates dose-depended effectiveness in lightening up glioblastoma in a preclinical model

FluoGuide A/S’s (“FluoGuide”, ticker FLUO) compound FG001 lights up the cancer and has in preclinically studies demonstrated potential to vastly improve... [Read more]

September 6, 2019

Press release

Presentation of data where use of FG001 demonstrates improved surgical outcome in metastatic pancreatic cancer compared to standard surgery using only white light

FluoGuide A/S’s (“FluoGuide”, ticker FLUO) compound FG001 lights up the cancer and has in preclinically studies demonstrated potential to vastly improve... [Read more]

August 30, 2019

Press release

Interim Report Second Quarter 2019

FluoGuide today publishes its interim report for the period January – June 2019. The report is available here.   Andreas Kjær,... [Read more]

August 20, 2019

Press release

Strong preclinical data on FG001’s potential in guiding surgical removal of pancreatic cancer has been accepted for presentation on the World Molecular Imaging Congress 2019

FluoGuide A/S’s (“FluoGuide”) compound FG001 lights up the cancer and has demonstrated potential to vastly improve the radicality of surgery in... [Read more]

August 12, 2019

Press release

FG001 again demonstrates strong data in guiding glioblastoma surgery – accepted for presentation at the World Molecular Imaging Congress 2019

FluoGuide A/S (“FluoGuide”) today announces that new data confirms FG001’s potential in guiding surgical removal of glioblastoma. The data will be... [Read more]